
Harrow Health, Inc.
HROWNASDAQHealthcare● Active
$33.26
+$0.07(+0.20%)
Market Cap$1.2B
P/E Ratio—
52W High$54.85
52W Low$27.76
Harrow Health, Inc. (HROW) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · HROW · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.27B | $0.20B | $0.13B | $0.09B | $0.07B |
| Cost of Revenue | $0.07B | $0.05B | $0.04B | $0.03B | $0.02B |
| Gross Profit | $0.20B | $0.15B | $0.09B | $0.06B | $0.05B |
| Gross Margin %(computed) | 75.05% | 75.33% | 69.55% | 71.35% | 74.87% |
| Operating Expenses | |||||
| R&D Expenses | $0.01B | $0.01B | $0.01B | $0.00B | $0.01B |
| G&A Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Operating Expenses | $0.17B | $0.14B | $0.09B | $0.06B | $0.05B |
| Operating Income | $0.04B | $0.01B | $0.00B | $0.00B | $0.00B |
| Operating Margin %(computed) | 14.18% | 4.42% | 0.33% | 2.17% | 2.23% |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.02B | $0.02B | $0.02B | $0.01B | $0.01B |
| Income Before Tax | ($0.00B) | ($0.02B) | ($0.02B) | ($0.01B) | ($0.02B) |
| Income Tax Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Income | ($0.01B) | ($0.02B) | ($0.02B) | ($0.01B) | ($0.02B) |
| Net Margin %(computed) | -1.89% | -8.76% | -18.75% | -15.90% | -24.85% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.14 | $-0.49 | $-0.75 | $-0.51 | $-0.69 |
| Wtd Avg Shares | 0.04B | 0.04B | 0.03B | 0.03B | 0.03B |
| EBITDA | $0.06B | $0.02B | $0.01B | $0.00B | $0.01B |
| EBITDA Margin %(computed) | 21.12% | 11.08% | 9.18% | 5.36% | 7.04% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more Harrow Health, Inc. data
About Harrow Health, Inc. (HROW) Income Statement
Harrow Health, Inc. (HROW) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, HROW reported revenue of $0.27B, gross profit of $0.20B (gross margin 75.05%), and net income of ($0.01B) — a net profit margin of -1.89%.
Frequently asked questions
HROW · 4 questionsHarrow Health, Inc. (HROW) reported revenue of $0.27B for 2025, up 36.4% year-over-year.
HROW revenueHROW salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08